Aveanna Healthcare Holdings Files 8-K

TL;DR

Aveanna Healthcare Holdings signed a new deal, filing an 8-K with the SEC.

AI Summary

On September 30, 2024, Aveanna Healthcare Holdings Inc. entered into a material definitive agreement. The company also filed financial statements and exhibits as part of this report. Specific details of the agreement and financial information were not disclosed in the provided text.

Why It Matters

This filing indicates a significant event for Aveanna Healthcare Holdings, Inc., likely involving a new contract or financial arrangement that could impact its operations and future performance.

Risk Assessment

Risk Level: medium — The filing of an 8-K often signifies material events, which can introduce uncertainty or change the company's financial or operational landscape.

Key Players & Entities

• Aveanna Healthcare Holdings Inc. (company) — Registrant
• September 30, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-40362 (commission_file_number) — SEC File Number
• 81-4717209 (irs_number) — IRS Employer Identification No.
• 400 Interstate North Parkway SE (address) — Principal Executive Offices
• Atlanta (city) — Principal Executive Offices City
• Georgia (state) — Principal Executive Offices State
• 30339 (zip_code) — Principal Executive Offices Zip Code
• 770 441-1580 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share AVAH The Nasdaq Global Se
• $170.33 million — wing availability under the Revolver is $170.33 million through the unamended maturity date in
• $148.85 million — availability under the Revolver will be $148.85 million. All other material terms of the Credit

Filing Documents

• avah-20240930.htm (8-K) — 44KB
• avah-ex10_1.htm (EX-10.1) — 181KB
• avah-ex99_1.htm (EX-99.1) — 15KB
• img45841609_0.jpg (GRAPHIC) — 41KB
• 0000950170-24-112939.txt ( ) — 430KB
• avah-20240930.xsd (EX-101.SCH) — 23KB
• avah-20240930_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. As previously reported, on March 16, 2017, Aveanna Healthcare LLC ("Aveanna Healthcare"), a wholly owned subsidiary of Aveanna Healthcare Holdings Inc., a Delaware corporation (the "Company"), entered into the First Lien Credit Agreement (as amended, the "Credit Agreement") by and among Aveanna Healthcare as the borrower, certain of the Company's other subsidiaries as guarantors, Barclays Bank PLC, as administrative agent, and the other agents and lenders party thereto from time to time. On September 30, 2024, Aveanna Healthcare entered into the Tenth Amendment to First Lien Credit Agreement (the "Extension Amendment") together with certain of the Company's other subsidiaries, Barclays Bank PLC., as administrative agent, and the other agents and lenders party thereto, pursuant to which the maturity date of the revolving credit facility under the Credit Agreement (the "Revolver") has been extended from April 2026 to April 2028. Additionally, the Extension Amendment provides that effective immediately the maximum borrowing availability under the Revolver is $170.33 million through the unamended maturity date in April 2026 and then immediately following the unamended maturity date in April 2026, the maximum borrowing availability under the Revolver will be $148.85 million. All other material terms of the Credit Agreement remain unchanged. The foregoing description of the Extension Amendment is only a summary and is qualified in its entirety by reference to the full text of the Extension Amendment which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On October 4, 2024, the Company issued a press release with respect to the information disclosed in Item 1.01 of this Current Report on Form 8-K, a copy of which press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01. The information contained in this Item 7.01, including in Exhibit 99.1 and attached hereto, is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1* Extension Amendment, dated September 30, 2024, among Aveanna Healthcare LLC, Barclays Bank PLC, as administrative agent, and the other lenders, agents and guarantors party thereto. 99.1 Press Release dated October 4, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar attachments to this exhibit have been omitted because they do not contain information material to an investment or voting decision and such information is not otherwise disclosed in such exhibit. The Company will supplementally provide a copy of any omitted schedule or similar attachment to the U.S. Securities and Exchange Commission or its staff upon request.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVEANNA HEALTHCARE HOLDINGS INC. Date: October 4, 2024 By: /s/ Deborah Stewart Deborah Stewart Chief Accounting Officer (Principal Accounting Officer)

View Full Filing

View this 8-K filing on SEC EDGAR